These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 19539037)

  • 1. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a).
    Dalaker TO; Larsen JP; Bergsland N; Beyer MK; Alves G; Dwyer MG; Tysnes OB; Benedict RH; Kelemen A; Bronnick K; Zivadinov R
    Mov Disord; 2009 Nov; 24(15):2233-41. PubMed ID: 19768730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment.
    Kandiah N; Mak E; Ng A; Huang S; Au WL; Sitoh YY; Tan LC
    Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
    Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
    Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter correlations of cognition in incident Parkinson's disease.
    Dalaker TO; Zivadinov R; Larsen JP; Beyer MK; Cox JL; Alves G; Bronnick K; Tysnes OB; Antulov R; Dwyer MG; Aarsland D
    Mov Disord; 2010 Apr; 25(5):629-33. PubMed ID: 20213820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease.
    Lee SJ; Kim JS; Yoo JY; Song IU; Kim BS; Jung SL; Yang DW; Kim YI; Jeong DS; Lee KS
    Alzheimer Dis Assoc Disord; 2010; 24(3):227-33. PubMed ID: 20473133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.
    Dalaker TO; Zivadinov R; Ramasamy DP; Beyer MK; Alves G; Bronnick KS; Tysnes OB; Aarsland D; Larsen JP
    Mov Disord; 2011 Feb; 26(2):297-301. PubMed ID: 21412836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual rating of white matter hyperintensities in Parkinson's disease.
    Beyer MK; Aarsland D; Greve OJ; Larsen JP
    Mov Disord; 2006 Feb; 21(2):223-9. PubMed ID: 16161159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of white matter hyperintensities and medial temporal lobe atrophy in age-related executive dysfunctioning.
    Oosterman JM; Vogels RL; van Harten B; Gouw AA; Scheltens P; Poggesi A; Weinstein HC; Scherder EJ
    Brain Cogn; 2008 Nov; 68(2):128-33. PubMed ID: 18450353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
    Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
    J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter microstructural integrity and cognitive function in a general elderly population.
    Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
    Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function.
    Tiehuis AM; Vincken KL; Mali WP; Kappelle LJ; Anbeek P; Algra A; Biessels GJ
    Cerebrovasc Dis; 2008; 25(1-2):59-66. PubMed ID: 18033959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.